CMS Office of Policy
Executive Summary
AdvaMed Exec VP Carol Kelly will join the Centers for Medicare & Medicaid Services to head a newly formed Office of Policy June 13. Kelly will lead a staff drawn from CMS' current Planning & Policy Analysis Group within the Office of Research, Development & Information. ORDI's Mary Ellen Stahlman will be assistant director of the office. Kelly joined AdvaMed in 1999; she previously worked at CMS (formerly known as HCFA) from 1982-1986...
You may also be interested in...
AdvaMed adds HHS health policy adviser
Ann-Marie Lynch joins AdvaMed as exec VP-payment and healthcare delivery, bringing more than 15 years of health care policy experience to the post, the device trade group reports. Lynch served most recently as principal deputy assistant secretary in the HHS Office of the Assistant Secretary for Planning & Evaluation. She will join AdvaMed Oct. 24, succeeding exec VP Carol Kelly, who left the association in June to become director of CMS' new Office of Policy (1"The Pink Sheet" May 30, 2005, In Brief)....
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.